Paul Mullen, MD
Cardiovascular Disease · Biloxi, MSNPI 1114977451
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $19,837 of the $29,376 with a category attached, or 67.5%. 51 manufacturers reported payments, led by Abbott at 24.8% of the total. Reporting peaked in 2023 at $6,595 and has fallen 53.1% since, to $3,093 in 2025. Among cardiovascular disease clinicians in MS with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 977 payments — averaging $30.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$7K
- Medtronic$4K
- Boston Scientific$3K
- Bard Peripheral Vascular, Inc.$2K
- Novartis$2K
- Pfizer$1K
- plus $10K from 45 others
What the payments were for
- Travel & lodging$9,46432%
- Food & beverage$19,83768%
- Gifts$750%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AVEIR$3,021
- VersaCross Access Solution$2,028
- Reveal LINQ$1,854
- VENOVO$1,707
- HawkOne$986
- ENDOCROSS Device$497
- Torus Stent Graft System$497
- Xience Sierra Coronary Stent System$377
- Impella$345
- Optis Coronary Imaging System$302
- IGT Device Undivided$156
- FARXIGA$119
- Inpefa$113
- CardioMEMS HF System$109
- Mitra Clip system$109
- Watchman$102
- QUADRA ASSURA$102
- WATCHMAN FLX$101
How this compares
$29,376 in reported general payments places this provider in the 90th percentile of 144 cardiovascular disease providers in Mississippi.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 34 | $25,293 |
| XareltoRivaroxaban | 23 | $16,763 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 21 | $561 |
| Rosuvastatin Calcium | 39 | $383 |
| Atorvastatin Calcium | 81 | $285 |
| Amlodipine Besylate | 51 | $257 |
| Losartan Potassium | 30 | $244 |
| Ezetimibe | 25 | $212 |
| Metoprolol Succinate | 20 | $193 |
| Metoprolol Tartrate | 42 | $127 |
| Enalapril Maleate | 11 | $108 |
| Ramipril | 22 | $103 |
| Furosemide | 42 | $102 |
| Lisinopril | 36 | $78 |
| ClopidogrelClopidogrel Bisulfate | 12 | $65 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $1,281 | $25,29334 claims |
| Johnson & JohnsonXarelto | $1,005 | $16,76323 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 144 cardiovascular disease providers in Mississippi.
Other cardiovascular disease in Biloxi
- Antoine RizkBiloxi$28K
- Dharmesh PatelSouthaven$1.5M
- Barry BertoletTupelo$469K
- Donny StokesJackson$207K
- Mahmoud ZayedPascagoula$103K
- James BenslerJackson$64K
- Michael HallJackson$54K
- Hugo QuintanaPascagoula$48K
- Ediz TasanPascagoula$42K
- Lawrence LeaderHattiesburg$40K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.